Ready to play
Ready to play
Experimental peptides are gaining popularity among influencers and some health advocates despite lacking FDA approval for safety or efficacy. Although a recent White House proposal would increase access to unapproved peptides, scientific experts warn that many claims about their safety and therapeutic benefits are misleading, given the limited clinical research. The article emphasizes that peptides are drugs when used to treat or influence the body, contradicting common myths that they are natural or inherently safe, and highlights concerns about insufficient testing and potential risks.
Notice: This Is an AI-Generated Summary
Comments (0)